These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37599461)

  • 1. Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publication.
    Sada KE; Nagasaka K; Kaname S; Nango E; Kishibe K; Dobashi H; Hiromura K; Kawakami T; Bando M; Wada T; Amano K; Murakawa Y; Harigai M
    Mod Rheumatol; 2024 Mar; 34(3):559-567. PubMed ID: 37599461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis.
    Watanabe R; Oshima M; Nishioka N; Sada KE; Nagasaka K; Akiyama M; Ando T; Higuchi T; Inoue Y; Kida T; Mutoh T; Nakabayashi A; Onishi A; Sakai R; Waki D; Yamada Y; Yajima N; Tamura N; Kaname S; Harigai M
    Mod Rheumatol; 2023 Aug; 33(5):982-989. PubMed ID: 36112482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis.
    Harigai M; Nagasaka K; Amano K; Bando M; Dobashi H; Kawakami T; Kishibe K; Murakawa Y; Usui J; Wada T; Tanaka E; Nango E; Nakayama T; Tsutsumino M; Yamagata K; Homma S; Arimua Y
    Mod Rheumatol; 2019 Jan; 29(1):20-30. PubMed ID: 30001655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update on treatment of ANCA-associated vasculitis: Granulomatosis with polyangiitis and Microscopic Polyangiitis].
    Holle JU; Hellmich B; Moosig F
    Z Rheumatol; 2022 May; 81(4):280-285. PubMed ID: 35061059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database.
    Nagasaka K; Kaname S; Amano K; Kato M; Katsumata Y; Komagata Y; Sada KE; Tanaka E; Tamura N; Dobashi H; Nanki T; Harabuchi Y; Bando M; Homma S; Wada T; Harigai M
    Mod Rheumatol; 2022 Aug; 32(5):915-922. PubMed ID: 34918136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
    Hellmich B; Sanchez-Alamo B; Schirmer JH; Berti A; Blockmans D; Cid MC; Holle JU; Hollinger N; Karadag O; Kronbichler A; Little MA; Luqmani RA; Mahr A; Merkel PA; Mohammad AJ; Monti S; Mukhtyar CB; Musial J; Price-Kuehne F; Segelmark M; Teng YKO; Terrier B; Tomasson G; Vaglio A; Vassilopoulos D; Verhoeven P; Jayne D
    Ann Rheum Dis; 2024 Jan; 83(1):30-47. PubMed ID: 36927642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
    Singh D; Sukumaran S
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How best to manage relapse and remission in ANCA-associated vasculitis.
    Puéchal X; Guillevin L
    Expert Rev Clin Immunol; 2022 Nov; 18(11):1135-1143. PubMed ID: 36102147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Therapies for ANCA-associated Vasculitis.
    Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
    Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis.
    Berti A; Cornec D; Dua AB
    Rheum Dis Clin North Am; 2023 Aug; 49(3):545-561. PubMed ID: 37331732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ANCA-associated vasculitis].
    Krasselt ML; Holle JU
    Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?
    Tesar V; Hruskova Z
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1519-1521. PubMed ID: 32471814
    [No Abstract]   [Full Text] [Related]  

  • 14. Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Harigai M; Takada H
    Mod Rheumatol; 2022 Apr; 32(3):475-483. PubMed ID: 34984461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN; Woronik V; Halpern AS; Barbas CS
    J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Chung SA; Langford CA; Maz M; Abril A; Gorelik M; Guyatt G; Archer AM; Conn DL; Full KA; Grayson PC; Ibarra MF; Imundo LF; Kim S; Merkel PA; Rhee RL; Seo P; Stone JH; Sule S; Sundel RP; Vitobaldi OI; Warner A; Byram K; Dua AB; Husainat N; James KE; Kalot MA; Lin YC; Springer JM; Turgunbaev M; Villa-Forte A; Turner AS; Mustafa RA
    Arthritis Rheumatol; 2021 Aug; 73(8):1366-1383. PubMed ID: 34235894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1-treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
    Schirmer JH; Sanchez-Alamo B; Hellmich B; Jayne D; Monti S; Luqmani RA; Tomasson G
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37479496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.